|
Press Releases |
|
|
|
Tuesday, June 27, 2023 |
|
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA |
Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, the "Group", HKEX stock code: 0460) is pleased to announce that Xuanzhu Biopharmaceutical Co., Ltd. ("Xuanzhu Biopharm"), a non-wholly owned subsidiary of Company, has received a drug registration approval from the National Medical Products Administration (the "NMPA") of China of Anaprozole Sodium Enteric-coated Tablet for the treatment of duodenal ulcer. more info >> |
|
Monday, June 19, 2023 |
|
四环医药及轩竹生物齐入围《2023中国药品研发综合实力排行榜 TOP100》 |
四环医药控股集团有限公司( 「公司」或 「四环医药」,连同其附属公司,统称「集团」;港交所股份代号:0460)欣然宣布,集团与旗下子公司轩竹生物科技股份有限公司(「轩竹生物」)双双跻身《2023中国药品研发综合实力排行榜 TOP100》,分别位列第21名和第100名。 more info >> |
|
四環醫藥及軒竹生物齊入圍《2023中國藥品研發綜合實力排行榜 TOP100》 |
四環醫藥控股集團有限公司( 「公司」或 「四環醫藥」,連同其附屬公司,統稱「集團」;港交所股份代號:0460)欣然宣佈,集團與旗下子公司軒竹生物科技股份有限公司(「軒竹生物」)雙雙躋身《2023中國藥品研發綜合實力排行榜 TOP100》,分別位列第21名和第100名。 more info >> |
|
Thursday, June 8, 2023 |
|
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development, Presents major research results of birociclib, the start product, at the international stage in ASCO |
Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, the "Group", HKEX stock code: 0460) is pleased to announce that the Group recently attended the 59th American Society of Clinical Oncology (ASCO) annual meeting in Chicago, the United States with its major research results more info >> |
|
四环医药旗下轩竹生物创新研发全速前进 携明星产品吡罗西尼重磅研究成果登国际舞台于ASCO亮相 |
四环医药控股集团有限公司( 「公司」或 「四环医药」,连同其附属公司,统称「集团」;港交所股份代号:0460)欣然宣布,集团日前携重磅研究成果出席于美国芝加哥举行的第59届美国临床肿瘤学会(ASCO),会上展示了旗下轩竹生物自主研发的创新型CDK4/6抑制剂吡罗西尼单药治的疗多线治疗(包括内分泌治疗和化疗)后进展的HR+/HER2-转移性乳腺癌的良好疗效 more info >> |
|
四環醫藥旗下軒竹生物創新研發全速前進 攜明星產品吡羅西尼重磅研究成果登國際舞台於ASCO亮相 |
四環醫藥控股集團有限公司( 「公司」或 「四環醫藥」,連同其附屬公司,統稱「集團」;港交所股份代號:0460)欣然宣佈,集團日前携重磅研究成果出席於美國芝加哥舉行的第59屆美國臨床腫瘤學會(ASCO),會上展示了旗下軒竹生物自主研發的創新型CDK4/6抑制劑吡羅西尼單藥治的療多線治療(包括內分泌治療和化療)後進展的HR+/HER2-轉移性乳腺癌的良好療效 more info >> |
|
Friday, March 24, 2023 |
|
四环医药(0460.HK)发布2022年全年业绩 |
四环医药控股集团有限公司(港交所股份代号:0460)(「四环医药」或「公司」,连同其附属公司,统称「集团」)宣布其截至2022年12月31日止(「年内」)之全年业绩。 more info >> |
|
四環醫藥(0460.HK)發佈2022年全年業績 |
四環醫藥控股集團有限公司(港交所股份代號:0460)(「四環醫藥」或「公司」,連同其附屬公司,統稱「集團」)宣佈其截至2022年12月31日止(「年內」)之全年業績。 more info >> |
|
Sihuan Pharmaceutical (0460.HK) Announces 2022 Annual Results |
Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460) ("Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") announces its annual results for the year ended 31 December 2022 (the Year). more info >> |
|
Wednesday, January 4, 2023 |
|
四环医药(0460.HK):惠升生物成功完成A +轮融资,加速糖尿病及并发症领域布局 |
四环医药控股集团有限公司( “公司”或 “四环医药”,连同其附属公司,统称“集团”;港交所股份代号:0460)欣然宣布,集团旗下非全资附属公司吉林惠升生物制药有限公司(「惠升生物」)已成功完成由吉林百兴百荣投资中心(有限合伙)(“百兴百荣”) more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
綠竹生物:2023年度業績發表會圓滿舉行
May 6, 2024 14:00 HKT/SGT
|
|
|
绿竹生物:2023年度业绩发布会圆满举行
May 6, 2024 13:55 HKT/SGT
|
|
|
CropLife Asia announces new Office Bearers for 2024
May 6, 2024 13:00 HKT/SGT
|
|
|
健倍苗苗发布盈喜
May 5, 2024 11:00 HKT/SGT
|
|
|
健倍苗苗發佈盈喜
May 5, 2024 11:00 HKT/SGT
|
|
|
JBM Healthcare Issues Positive Profit Alert
May 5, 2024 11:00 HKT/SGT
|
|
|
Aemetis to Review First Quarter 2024 Financial Results on May 9, 2024
May 4, 2024 01:00 HKT/SGT
|
|
|
Peapack Private Hires Jerry Dominguez as Senior Managing Director
May 4, 2024 01:00 HKT/SGT
|
|
|
UVify Sets New Guinness World Record With 5,293 IFO Drones in Spectacular Aerial Display
May 4, 2024 00:00 HKT/SGT
|
|
|
2024 CAP Consumer Survey Shows Increase in Piracy on Social Media and Messaging Platforms in Asia Pacific
May 3, 2024 20:40 HKT/SGT
|
|
|
Singapore's top general insurer debuts trading on Asia's leading digital exchange, AltaX
May 3, 2024 10:30 HKT/SGT
|
|
|
Nephros Schedules First Quarter 2024 Financial Results Conference Call
May 3, 2024 08:31 HKT/SGT
|
|
|
Nass Valley Gateway Ltd Announces It Will File Its 2023 EOY Audited Financials by June 28th, 2024, Within the Extension Granted by the BCSC
May 3, 2024 08:26 HKT/SGT
|
|
|
UPDATE: Kaplan Fox Files Class Action to Recover Losses for Investors Who Were Short The Barclays Bank PLC iPath Series B S&P 500 VIX Short-Term Futures ETN (CBOE: VXX) ("VXX")
May 3, 2024 08:05 HKT/SGT
|
|
|
长江电力公布2023年年度业绩 营收利润双增长
May 2, 2024 23:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|